Emily Quann Alonzo is the Director of Immunology and Immuno-Oncology Product Design and Strategy at Cell Signaling Technology. Prior to joining CST, Emily was a postdoctoral research scientist in the Immunology Program at Memorial Sloan Kettering Cancer Center. She received her BS in Chemical Engineering from the University of Virginia and her PhD in Cell Biology from Georgetown University.
